Manufacture highly precise, injection-molded plastic components. Now — the numbers.
This is an established company with proven profits.
No real growth (-3% a year). Red columns mark years that ended in a loss.
The gap is $32.4M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 13.5× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
No analyst target is on record for this company.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are going backwards, not just slowing.
The stock trades 20% below its peak. The market has trimmed its expectations for the company.
Our checks did not surface a specific strength to highlight here.
The stock sits at $0.67. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
Over the last 4 years, sales fell about 3% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.